| 863
LEE MORTENSEN ET aL. beginning school, leisure activities, adolescence, moving out from home, establishing new relationships and choosing a career. 15, 16 Treatment adherence is mainly challenged at two transition points: when young people with haemophilia (YWH) switch to self-infusion and when they move away from home and assume the full responsibility of self-care. 16, 17 Among haemophilic patients in the Western world, adolescents (13-17-year-olds) and young adults (18 to 25-30-year-olds depending on the study) reportedly have the lowest adherence levels compared to other age groups. 2, [11] [12] [13] [14] [17] [18] [19] [20] [21] These patients go through major physical and psychosocial changes challenging the transition to self-care. 15, 16, [22] [23] [24] [25] [26] [27] [28] [29] Haemophilia treatment centres (HTC) are variously organized creating different challenges to transition support. 2, 15 In clinical practice, a systematic approach to transition is rarely used, however, and there is little evidence on best practices. 15, 22, 29 The present qualitative review examined adherence to PTX in YWH. [30] [31] [32] [33] [34] We aimed to gain comprehensive insight into main drivers and barriers to adherence by exploring them in the context of YWH's disease perceptions, characteristics, health-related QoL and needs. 1, 13, 14, The outcome is an overview of the latest published recommendations to support treatment adherence in YWH during the transition from family-oriented care to self-care and from paediatric to adult care. for quantitative and qualitative study reports as well as reviews. The final search strategy covered four main topics including related concepts: adherence, quality of life, self-care and transition in combination with haemophilia and youth (example given in Figure 1 ) and yielded a total of 718 unique articles. A review of titles and abstracts revealed that only few studies published before 2012 were relevant to our research focus. We therefore limited the search to 2012-2017 but kept nine older articles deemed to be informative to our purpose. 2 72 This qualitative review constitutes an interpretive synthesis of the highest quality literature sources shedding light on the topic of adherence to PTX in YWH.
| MATERIAL S AND ME THODS
On a final introductory note, a key conceptual distinction exists between "adherence," that is, patients complying with doctor's recommendations of a rather strict treatment plan and "concordance"
involving a more equal patient-physician agreement on a mutually acceptable and possibly flexible treatment program. 12, [69] [70] [71] This review uses "adherence" as an umbrella term to cover any approach employed by the authors. Also, we use the term "treatment" when studies included on-demand treatment as well as PTX.
TA B L E 1 Barriers to treatment adherence in haemophilia

Domains
Main themes Sub-themes References
Clinical issues Burden of treatment High perceived burden of treatment: PTX perceived as inconvenient, time-consuming and interfering with activities 6, 8, 11, 14, 20, 31, 36, 37, 75 Time of day: morning infusion is especially challenging 7 Lacking treatment routines 12, 31 Injection issues, for example, lacking skills, venous access and needle phobia 3, 6, 8, 9, 40, 41, 69 Treatment dissatisfaction 5 
Symptoms
Milder disease severity 11, 19 No or infrequent bleeding episodes/No or low burden/fear of symptoms (good HRQoL) 5, 7, 11, 12, 31, 32, 68 Patient characteristics Knowledge/cognition Lacking knowledge about disease and treatment 5, 8, 31, 40, 41, 68 Lacking perception of the benefit of treatment 18, 19, 32, 68 Forgetfulness 7, 9, 11, 40 Difficulties with irregular situations and planning 31, 68 Psychological issues Cultural/language difficulties 69 Poor self-efficacy, self-management and coping 12, 21, [37] [38] [39] [40] Lacking disease acceptance/denial (incl. deliberate rejection) 31, 42 Negative emotions (eg, negative self-image, loneliness) 21, 32, 38, 59 Few negative emotions/good HRQoL 32 Age Youth: transition to self-infusion, adult and self-care [5] [6] [7] [8] 12, 16, 17, [20] [21] [22] [24] [25] [26] [27] [28] 30, 34 Social issues Caregiver support Poor social support 8, 21, 38 Inadequate parental support, for example, over-protection and control 9, 23, 38 Impact on relations and activities Restrictions in social activities, for example, sports, negative impact on social relations and disclosure issues 9, 42 Strive for normalcy, wanting to be and do like healthy peers 2, 36, 37 Health care issues Cost Lacking coverage of treatment costs 19, 21, 47, 59 HCP not prescribing PTX due to assumed non-adherence (due to coverage issues) 20 
Patient-HCP relations Organization
Poor relations to the HCP/little time spent in HTC 5 Lacking transition planning 16, 22, 23, 54 Cultural differences/gap between paediatric and adult care, lacking collaboration between HCP 23 3 | RE SULTS
| Examining adherence in haemophilia
Treatment adherence in haemophilic patients has received increased attention in later years, yet various methods and definitions of adherence have led to highly divergent results. For instance, some studies used simple dichotomous cut-off at ≥75% patient-reported uptake of recommended doses to distinguish adherence from non-adherence (eg, Refs. [11] [12] [13] 18 ); others applied pharmacy prescription claims cutting off at ≥60% days' supply 8, 19 (Appendix S1 Concordant TX collaboration between patient and HCP 11, 36, 37 Integration of treatment in everyday life/good infusion routines 31, 36, 37, 68 Low perceived burden of treatment/treatment satisfaction 5, 12, 20, 68 Online support and reminder systems 5, 11, 19, 35 Easier reconstitution procedures (tablets/syringe systems) and storage 2, 11 Symptoms Experience with and fear of bleeding episodes/ symptoms 5, 7, 12, 31, 68 Patient characteristics Knowledge/cognition Knowledge about disease and treatment 5, 11, 68 Perceived need and benefit of treatment 12, 20, 21, 32, 33, 68 Skill in planning and coping with irregular situations, using situational cues 16, 23, 29, 31, 68 Psychological issues Disease acceptance 7, 12, 21, 22, 31, 32, 68 Self-efficacy 12, 21, 22, 31, 33, 37, 39, 40, 42 Few negative emotions: good self-esteem, unaffected self-perception, feeling normal and good HRQoL 12, 15, 22, 32, 36, 37 Age Parental care, caregiver infusion 6, 7, 22 Social issues Caregiver support Good social (especially parental) support 21, 64 Adequate parental support in developing patients' disease acceptance, self-care and self-efficacy 12, 15, 22, 23, 33, 34, 38, 64 Social relations and participation PTX seen as allowing a normal social and active life 31, 36, 37, 68 Participation in social activities with healthy peers/ less negative social impact/counselling about recommended physical activity 9, 12, 22, 33, 42 Knowledge of other patients' experiences/peer support 43, 44, 46 Health care issues Cost Free public health care/coverage of treatment costs 11, 15 Patient-HCP relations Organization
Good relations to the HCP 5, 11, 12, 22 Time spend at HTC 5, 11 Intensified support at transition points/transition planning 11, 16, 17, 23, 29, 34, 54 Tailored individual support adherence, it has not been found entirely applicable in health care
settings with a more concordant treatment approach. 21 In a study from six European countries, 60% of patients described their relationship with the HCP as concordant.
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In haemophilia, reported levels of treatment adherence range from 44%-87%. 7 Overall, adherence rates are high in Western Europe (80%-87%) where health care is mostly public. 2, 11, 12, [19] [20] [21] Here, a concordant rather than compliant understanding of adherence may also act to augment adherence rates. 36 Adherence tends to be highest in childhood (≤12 years) and lowering in adolescents and young adults corresponding to the transition from parental care to self-care. 1, 2, 6, 7, 9, 15, 17, 20, 21, 33, 64 In a global survey, adherence dropped from 90% to 54% when 13-18-year-olds started self-infusing. 33 In the USA, non-adherence rose from 17% in 13-17-yearolds to 47% in 18-25-year-olds. 17, 34 It has been shown that up to 2/3 of YWH may experiment with stopping or reducing PTX.
1,5,9,24
| Factors influencing treatment adherence in haemophilic patients
Transition interventions to sustain treatment adherence in YWH should be evidence-based. One useful way to conceptualize identi- Treatment adherence is strongly associated with haemophilic patients' HRQoL that, interestingly, is related to similar factors: symptoms and treatment, physical and emotional functioning, social support, age/situation in life and the health care system. 14, 57, 59, 61 In Tables 1 and 2 , we present identified barriers and drivers, each organized in the four domains containing analytical themes and subthemes, including references to original studies finding each factor.
| Adherences issues in adolescents and young adults with haemophilia
Some barriers and drivers affect patients' adherence more than others and patients' perceptions of gains and losses may lead to different behaviours. 31 Also, respondent scores on the six VERITAS-Pro scales vary with age, implying that YWH may be particularly affected by specific factors. Conversely, experiences with bleeds, fear of symptoms and integration of PTX in daily routines are main drivers for adherence. 7, 12, 30 The latter has been related to early and personalized treatment according to the patient's pharmacokinetic profile, activity level and self-management skills. 45 In the UK, concordant-individualized and flexible-treatment planning has been shown to enhance adherence and QoL in YWH. Forgetfulness, poor self-management and self-efficacy as well as lacking disease acceptance are crucial barriers. 1, 13, 20, 21, 27, 31, [35] [36] [37] [38] [39] [40] [41] 46, [49] [50] [51] [52] [53] [54] 59 Full self-management includes "the ability to seek, understand and apply health information to participate in health decisions and the daily management of symptoms and treatment as well as the physical and psychosocial consequences and lifestyle changes following from chronic disease" (our italics). 37, 40 These abilities may be extraordinarily challenged by the physical, cognitive and psychosocial changes occurring in YWH. only may this lead them to prioritize immediately rewarding activities, they may also have positive experiences with rapid resolution of pain following on-demand treatment-as opposed to a negative perception of the long haul of prevention with PTX. 9 Some abstain from physical activity 13, 42 while others engage in risky behaviour to prove themselves and "be alike". 33, 37, 44 Qualitative studies identified four distinct patient typologies and behavioural approaches to PTX. One found that the most adherent patients were those following a routine schedule and using situational cues, that is, taking extra infusions prior to physical activities requiring added protection. These patients were mostly physically active and considered treatment as a means to keep doing the things they wanted to. The second most adherent patients were those using only situational cues. They would often be >25 years old, less physically active but knowledgeable and satisfied with treatment. Third were patients following a strict routine but not using cues. They often had many childhood bleeds and were physically inactive. Least adherent patients were rarely using any treatment, had joint damage and lacked knowledge of disease and treatment. 68 This analysis is supported by a study identify- disease denial, perception of PTX as a confrontation with illness and conscious non-adherence. 31 Besides knowledge and perceived benefit, disease acceptance and good psychological coping are thus main drivers to treatment adherence that should be supported. 4, 11, 15, 21, [24] [25] [26] [27] 34, 47, 59, 64, 65 Here, increased independence, financial responsibility and engagement in adult relationships have been shown to be challenging to 18-30-year-old patients of whom many suffered from comorbidity, depression and anxiety. 25, 47 In the USA, patients' QoL may be reduced by financial concerns whereas European patients are more focused on relations, everyday activities and normalization. 59, 60 While adherence decreases in young adults in the USA, it tends to increase in the UK where young adults show increased perception of needing PTX, better self-efficacy and self-care and less need for social support compared to adolescents. 21, 37 Finally, the quality of HCP relations has major impact on treatment adherence. 4, 5, 12, 30, 59, 60, 64, 65 Linked to this is the frequency of visits to the HTC as well as the quality of collaboration between paediatric and adult HCPs. As we shall elaborate below, multidisciplinary collaboration and structured transition planning are central elements of the latest recommendations to secure PTX adherence into adult life.
| Recommendations to support treatment adherence through the transition to adult and selfcare
To ensure treatment adherence through the transition into adulthood, a main recommendation in the literature is to support the development of young patients' self-efficacy and self-management skills, including psychosocial coping. 1, 12, 13, 21, 23, 25, 32, [35] [36] [37] [38] [39] [40] [41] 46, [49] [50] [51] Full self-management includes routine integration in everyday life and the ability to use situational cues. 30, 31, 37, 50, 60, 68, 70 Learning self-management should supplement traditional patient education focused on information and technical skills. This is especially relevant in children and adolescents as interventions focusing solely on knowledge are ineffective in paediatrics. 33, 51 As adherence is particularly challenged during the transition to selfcare, intensified support is suggested in YWH. 15, 17, 18, 34 It is stressed, however, that education in self-care should start prior to puberty when
patients are more open-minded. 16, 24, 26, 27, 29, 51 One study showed that while the first steps in self-management were taken around the age of 12, it took almost ten years with gradual acquirement of more complex skills before complete self-management was achieved. 40 Recent publications recapitulate the recommendations for HCP to deal with the specific challenges for each phase of life with self-management education of caregivers and patients starting as early as possible. 1, 16, 40, 50 It is noticeable that while parents and HCP often focus on smoothing out cultural differences between paediatric and adult care, YWH emphasize a preference for being well prepared for the shift from family-centred to individual-centred care, for example, through joint meetings with paediatric and adult HCP, visits to the adult care clinic, and seeing
HCPs alone prior to the final transition. 15, 23, 29, 40 Supporting HRQoL and adherence in YWH is thus a process beginning in early childhood and requiring a family-oriented approach. 1, 22, 28, 33, 34, 50 There is no "one size fits all" intervention to improve self-management. Individual drivers and barriers to adherence, needs and preferences must be continuously assessed and followed up with age-relevant tailored support from a multidisciplinary HCP team. 1, 7, 16, 27, 40, 50 Recommended transition strategies include the development of a structured transition plan, monitoring processes with systematic assessments of patients' readiness, individualized support and confirmation of effective transfer to adult care 1, 15, 16, [22] [23] [24] [25] [26] [27] [28] [29] 54 (Table 3) . Added support may be required when YWH switch to self-infusion and later move away from home. 17, 18 Haemophilia-specific tools to support the transition include the Six integral to discussions about whether PTX may be replaced by ondemand treatment at some age. 9, 11, 16, 21, 34 Psychosocial support should be central in interventions to support adherence in YWH. 21, 25, 32, 50, 57, 59, 63 Patients should learn strategies to cope with their illness and its daily management. 60 From early childhood, patients should learn to focus on wellness and empowerment rather than illness and strict adherence and to consider PTX as a means-rather than an obstacle-to leading a normal life. 14, 34, 36, 50, 60, 68 In the UK, a concordant treatment approach has allowed teens to feel that PTX enables them to "forget about haemophilia and be like their normal peers". 36, 37 QoL and adherence are closely related, and paediatric patients should be supported by HCP and caregivers in developing self-efficacy and self-management to create a situation of normality which is crucial to adherence to PTX in YWH. 51, 60 To optimize clinical outcomes focus is increasingly on personalizing haemophilic treatment to each patient's unique disease course, bleeding phenotype, joint status, pharmacokinetic profile, comorbidity, venous access, needs, lifestyle and adherence issues. 4, 9, 24, [64] [65] [66] [67] 74 The impact on adherence of new extended half-life products is a topic receiving increased attention, yet remains to be seen. 2, 4, 6, 11, 20, [64] [65] [66] 70, 74, 75 All things considered, the literature indicates that in order to support adherence, any treatment decision should be based on a concordant approach taking the individual patient's self-management skills, needs and preferences into consideration. 4, 11, 30, 36, 45, 50, 64, 68, 70 Sustaining treatment adherence in YWH requires a multidisciplinary biopsychosocial approach to patients and their caregivers. 
| D ISCUSS I ON
| CON CLUS ION
A main need for YWH is to obtain or preserve normality. At the heart of their adherence behaviour lies a perception of PTX as impeding or TA B L E 3 Key recommendations to sustain treatment adherence in young haemophilic patients
• The transition from paediatric to adult care should be a purposeful planned process. • Transition guidelines have been developed that may be adapted and applied.
• A detailed transition plan should include milestones and systematic assessments from infancy to full self-care in adulthood.
• Regular assessments should identify self-management gaps and be followed up with individualized multidisciplinary biopsychosocial support.
• Each transition may require re-education of patients as well as caregivers.
• Parents should learn to avoid over-protection and support their child's independence and self-efficacy.
• Transition preparation should involve early patient education in all-round self-management, including psychosocial coping (focusing on enablement, empowerment and normalization).
• Collaboration procedures should be established between paediatric and adult HCP, for example, joint consultations, consultations without parental presence and early visits to adult care clinic.
• Haemophilia-specific websites offering information and peer support options.
facilitating normality, obstructing or enabling their preferred life and activities. Fortunately, such core perceptions are amenable to being shaped by caregivers and HCPs from early childhood. Paediatric haemophilic patients should be individually supported in developing allround self-management competency in order to successfully traverse transitions and preserve good HRQoL into adulthood.
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